These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1862761)
21. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S; J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411 [TBL] [Abstract][Full Text] [Related]
22. Chemotherapy of metastatic Merkel cell cancer. Crown J; Lipzstein R; Cohen S; Goldsmith M; Wisch N; Paciucci PA; Silverman L; Weiner M; Jaffrey I; Norton L Cancer Invest; 1991; 9(2):129-32. PubMed ID: 1863871 [TBL] [Abstract][Full Text] [Related]
23. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results. Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333 [TBL] [Abstract][Full Text] [Related]
24. [Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma]. Zheng W; Zhu J; Xie Y Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):875-6. PubMed ID: 19173838 [No Abstract] [Full Text] [Related]
25. Administration of cisplatin and etoposide during chronic ambulatory peritoneal dialysis. Lee CW; Fabbro J Clin Oncol (R Coll Radiol); 2005 Dec; 17(8):667. PubMed ID: 16372502 [No Abstract] [Full Text] [Related]
26. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team. Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Nagasawa S Cancer; 1994 Mar; 73(6):1678-85. PubMed ID: 7512436 [TBL] [Abstract][Full Text] [Related]
27. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung. Murray N; Shah A; Brown E; Kostashuk E; Laukkanen E; Goldie J; Band P; Van den Hoek J; Murphy K; Sparling T Semin Oncol; 1986 Sep; 13(3 Suppl 3):24-30. PubMed ID: 3020695 [TBL] [Abstract][Full Text] [Related]
28. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204 [TBL] [Abstract][Full Text] [Related]
29. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin. Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559 [TBL] [Abstract][Full Text] [Related]
30. Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre. Hui AC; Stillie AL; Seel M; Ainslie J Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1430-5. PubMed ID: 20708847 [TBL] [Abstract][Full Text] [Related]
32. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma. Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic pitfalls of Merkel cell carcinoma and dramatic response to chemotherapy. Chang SF; Suh JW; Choi JH; Yoon GS; Huh J; Sung KJ; Moon KC; Kim WG; Koh JK J Dermatol; 1998 May; 25(5):322-8. PubMed ID: 9640886 [TBL] [Abstract][Full Text] [Related]
34. Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide. Fenig E; Brenner B; Njuguna E; Katz A; Schachter J; Sulkes A Am J Clin Oncol; 2000 Feb; 23(1):65-7. PubMed ID: 10683081 [TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study. Collins C; Higano CS; Livingston RB; Griffin BR; Keppen MD; Miller TP Cancer Chemother Pharmacol; 1989; 24(2):128-32. PubMed ID: 2543513 [TBL] [Abstract][Full Text] [Related]
36. Experience of a German multicenter study group with ifosfamide in small cell lung cancer. Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648 [TBL] [Abstract][Full Text] [Related]
37. [Image of the month. Merkel cell tumor: response to chemotherapy]. Polus M; Piront P; Jerusalem G; Sautois B; Defechereux T; de Leval L; Fillet G Rev Med Liege; 2004 Feb; 59(2):67-8. PubMed ID: 15112893 [No Abstract] [Full Text] [Related]
38. Long term results of surgery and chemotherapy in small cell lung cancer. Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145 [TBL] [Abstract][Full Text] [Related]
39. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Poulsen MG; Rischin D; Porter I; Walpole E; Harvey J; Hamilton C; Keller J; Tripcony L Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):114-9. PubMed ID: 16125873 [TBL] [Abstract][Full Text] [Related]
40. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer. Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]